BARCLAYS PLC - LEGEND BIOTECH CORP ownership

LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 3 filers reported holding LEGEND BIOTECH CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of LEGEND BIOTECH CORP
ValueSharesWeighting
Q3 2023$18,881
+226.6%
281,094
+235.7%
0.01%
+200.0%
Q2 2023$5,781
-46.4%
83,737
-62.5%
0.00%
-20.0%
Q1 2023$10,779
-57.1%
223,538
-55.6%
0.01%
-58.3%
Q4 2022$25,123
-99.8%
503,254
+67.1%
0.01%
-7.7%
Q3 2022$12,289,000
-23.7%
301,212
+2.8%
0.01%
+30.0%
Q2 2022$16,111,000
+80.7%
292,912
+19.4%
0.01%
+42.9%
Q1 2022$8,915,000245,3260.01%
Other shareholders
LEGEND BIOTECH CORP shareholders Q4 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 1,629,173$89,605,00022.89%
Paradigm Biocapital Advisors LP 978,596$53,823,00010.73%
FengHe Fund Management Pte. Ltd. 475,263$26,139,00010.25%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 1,222,342$67,229,0009.65%
HHLR ADVISORS, LTD. 4,436,617$244,014,0005.23%
Iron Triangle Partners LP 495,329$27,243,0003.53%
Parkman Healthcare Partners LLC 117,807$6,479,0002.39%
AtonRa Partners 28,172$1,549,0001.42%
Vivo Capital, LLC 244,375$13,441,0001.35%
Avidity Partners Management LP 1,000,000$55,000,0001.26%
View complete list of LEGEND BIOTECH CORP shareholders